The regulation of cortisol levels before Jane's treatment involves the hypothalamus, the pituitary gland, and the adrenal glands. The hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH then stimulates the adrenal glands to secrete cortisol.
ACTH travels through the bloodstream from the pituitary gland to the adrenal glands, where it stimulates the secretion of cortisol.
The unique pathway described in 2 helps regulate cortisol levels in the body by providing a feedback mechanism. When cortisol levels are low, the hypothalamus secretes CRH, which stimulates the pituitary gland to release ACTH. ACTH then stimulates the adrenal glands to produce cortisol. When cortisol levels are high, the hypothalamus and pituitary gland are inhibited from secreting CRH and ACTH, respectively, which results in decreased cortisol secretion by the adrenal glands.
The effector organs of cortisol include the liver and skeletal muscle. Cortisol stimulates gluconeogenesis in the liver, which increases blood glucose levels. Cortisol also stimulates protein breakdown in skeletal muscle, which provides amino acids for gluconeogenesis and tissue repair.
The actions induced by cortisol in the liver and skeletal muscle help the body respond to stress by providing a source of energy for the brain and other tissues. This is important in a stress situation where the body needs to mobilize energy quickly to respond to a threat or challenge.
The cortisol treatment prescribed by Jane's doctor will result in increased cortisol levels in the body, which will suppress the immune system and help reduce inflammation during an acute flare-up of rheumatoid arthritis.
If Jane stops taking her medication too quickly, she may experience symptoms of cortisol withdrawal, such as fatigue, muscle weakness, and decreased blood pressure. This is because her body has become dependent on the exogenous cortisol to maintain normal physiological function, and sudden withdrawal can result in a deficiency of this hormone. Tapering the dose of the medication over time allows the body to gradually adjust to lower cortisol levels, which reduces the risk of withdrawal symptoms.